Mironid: New drug compound could tackle hereditary kidney disease

An international collaboration of scientists is working to develop a new class of drugs to treat a common genetic kidney disease that is a major cause of kidney failure with promising results.Glasgowbased biotech company Mironid has developed a compound to...